Repurposing the serotonin agonist Tegaserod as an anticancer agent in melanoma: molecular mechanisms and clinical implications
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Repurposing the serotonin agonist Tegaserod as an anticancer agent in melanoma: molecular mechanisms and clinical implications ; volume:39 ; number:1 ; day:21 ; month:2 ; year:2020 ; pages:1-16 ; date:12.2020
Journal of experimental & clinical cancer research ; 39, Heft 1 (21.2.2020), 1-16, 12.2020
- Urheber
-
Liu, Wei
Stachura, Paweł
Xu, Haifeng C.
Umesh Ganesh, Nikkitha
Cox, Fiona
Wang, Ruifeng
Lang, Karl S.
Gopalakrishnan, Jay
Häussinger, Dieter
Homey, Bernhard
Lang, Philipp A.
Pandyra, Aleksandra A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13046-020-1539-7
- URN
-
urn:nbn:de:101:1-2020051721334072795668
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Liu, Wei
- Stachura, Paweł
- Xu, Haifeng C.
- Umesh Ganesh, Nikkitha
- Cox, Fiona
- Wang, Ruifeng
- Lang, Karl S.
- Gopalakrishnan, Jay
- Häussinger, Dieter
- Homey, Bernhard
- Lang, Philipp A.
- Pandyra, Aleksandra A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents
Serotonin und Schlaf : die Befunde mit Agonisten
Drug repurposing against COVID-19: focus on anticancer agents
Therapie der opioidinduzierten Atemdepression durch Serotonin-Rezeptor-Agonisten
Repurposing metformin as a potential anticancer agent using in silico technique
Pharmacological challenge with a serotonin 1D agonist in alcohol dependence
Anticancer effect of terpenes: focus on malignant melanoma
Repurposing of anticancer drugs: in vitro and in vivo activities against Schistosoma mansoni
Anti-cancer effect of dung beetle glycosaminoglycans on melanoma
Anticancer effects of mifepristone on human uveal melanoma cells
Anti-cancer effects of lucidadiol against malignant melanoma cells
Drug repurposing
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents
Serotonin und Schlaf : die Befunde mit Agonisten
Drug repurposing against COVID-19: focus on anticancer agents
Therapie der opioidinduzierten Atemdepression durch Serotonin-Rezeptor-Agonisten
Repurposing metformin as a potential anticancer agent using in silico technique
Pharmacological challenge with a serotonin 1D agonist in alcohol dependence
Anticancer effect of terpenes: focus on malignant melanoma
Repurposing of anticancer drugs: in vitro and in vivo activities against Schistosoma mansoni
Anti-cancer effect of dung beetle glycosaminoglycans on melanoma
Anticancer effects of mifepristone on human uveal melanoma cells
Anti-cancer effects of lucidadiol against malignant melanoma cells
Drug repurposing
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents
Serotonin und Schlaf : die Befunde mit Agonisten
Drug repurposing against COVID-19: focus on anticancer agents
Therapie der opioidinduzierten Atemdepression durch Serotonin-Rezeptor-Agonisten
Repurposing metformin as a potential anticancer agent using in silico technique
Pharmacological challenge with a serotonin 1D agonist in alcohol dependence
Anticancer effect of terpenes: focus on malignant melanoma
Repurposing of anticancer drugs: in vitro and in vivo activities against Schistosoma mansoni
Anti-cancer effect of dung beetle glycosaminoglycans on melanoma
Anticancer effects of mifepristone on human uveal melanoma cells
Anti-cancer effects of lucidadiol against malignant melanoma cells